There’s 99.9% similarity across human genomes, with the remaining 0.1% variation being what makes each person unique.1 In ...

Data provide insights that informed the Phase 1 study of STK-002 as a potential disease-modifying medicine for ADOA, including disease etiology, progression and clinical assessments –– ADOA is a rare ...